Chase Davis H, Stein Alicia, Grinshpun Daniel E, Krone Mackenzie W, Crews Craig M
Department of Chemistry, Yale University, New Haven, Connecticut 06511, United States.
Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, United States.
J Am Chem Soc. 2025 Jul 16;147(28):24527-24537. doi: 10.1021/jacs.5c05036. Epub 2025 Jul 2.
Cereblon (CRBN) is one of the most widely co-opted E3 ligase substrate receptor proteins in targeted protein degradation (TPD), and several CRBN-recruiting degraders are currently in late-stage preclinical evaluation. While the diversity of CRBN-recruiting moieties has rapidly expanded, the glutarimide ring has remained largely conserved in these ligands. Glutarimides can form during protein cleavage events via the intramolecular cyclization of glutamine within the protein backbone. Inspired by this biological mechanism, we developed CRBN-recruiting prodegraders by replacing the glutarimide in parent degraders with uncyclized glutamine analogs. Prodegraders derived from a potent, cytotoxic GSPT1 degrader exhibited cyclization, resulting in GSPT1 degradation. Optimization of the prodegrader scaffold revealed that glutarimide cyclization rates─and consequently, degradation kinetics─were tunable, with the most optimized prodegrader displaying degradation efficacy and cytotoxicity comparable to the parent, glutarimide-containing GSPT1 degrader. Furthermore, this prodegrader strategy can be readily applied to other known CRBN-based molecular glues and PROTACs. In contrast to conventional glutarimide-containing degraders, the amide of the prodegrader scaffold provides an accessible conjugation handle for stimulus-sensitive groups. We show that prodegraders can be conjugated to and released from a photolabile protecting group and a commonly used cathepsin-cleavable degrader-antibody conjugate (DAC) linker. Therefore, these prodegrader scaffolds introduce a generalizable conjugation strategy for CRBN-recruiting degraders to DAC linkers, eliminating the need for extensive degrader modifications to incorporate a conjugation handle. Overall, these findings establish the feasibility of utilizing glutamine analogs as a CRBN-recruiting prodegrader strategy and highlight their potential application in targeted drug delivery systems.
Cereblon(CRBN)是靶向蛋白质降解(TPD)中最广泛被利用的E3连接酶底物受体蛋白之一,目前有几种招募CRBN的降解剂正处于临床前后期评估阶段。虽然招募CRBN的部分的多样性迅速扩大,但戊二酰亚胺环在这些配体中基本保持不变。戊二酰亚胺可在蛋白质裂解过程中通过蛋白质主链内谷氨酰胺的分子内环化形成。受此生物学机制启发,我们通过用未环化的谷氨酰胺类似物取代母体降解剂中的戊二酰亚胺,开发了招募CRBN的前体降解剂。源自一种强效细胞毒性GSPT1降解剂的前体降解剂表现出环化,导致GSPT1降解。对前体降解剂支架的优化表明,戊二酰亚胺环化速率以及因此的降解动力学是可调的,最优化的前体降解剂显示出与含戊二酰亚胺的母体GSPT1降解剂相当的降解效果和细胞毒性。此外,这种前体降解剂策略可以很容易地应用于其他已知的基于CRBN的分子胶和PROTAC。与传统的含戊二酰亚胺降解剂相比,前体降解剂支架的酰胺为刺激敏感基团提供了一个可及的共轭手柄。我们表明,前体降解剂可以与光不稳定保护基团和常用的组织蛋白酶可裂解降解剂 - 抗体缀合物(DAC)接头共轭并从中释放。因此,这些前体降解剂支架为将招募CRBN的降解剂与DAC接头进行共轭引入了一种通用策略,无需对降解剂进行广泛修饰以纳入共轭手柄。总体而言,这些发现确立了利用谷氨酰胺类似物作为招募CRBN的前体降解剂策略的可行性,并突出了它们在靶向药物递送系统中的潜在应用。